| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/JCEM-65-1-53 |
| P698 | PubMed publication ID | 3584399 |
| P2093 | author name string | Jackson JA | |
| Kleerekoper M | |||
| Parfitt AM | |||
| Villanueva AR | |||
| Frame B | |||
| Rao DS | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteoporosis | Q165328 |
| P304 | page(s) | 53-58 | |
| P577 | publication date | 1987-07-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Bone histomorphometry in hypogonadal and eugonadal men with spinal osteoporosis. | |
| P478 | volume | 65 |
| Q35432980 | Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis |
| Q40723633 | Aetiologies of male osteoporosis: identification procedures |
| Q74024001 | Age-related changes in bone density among healthy Greek males |
| Q36038932 | Alcohol's harmful effects on bone. |
| Q33607522 | Androgen deficiency and aging in men. |
| Q53534635 | Androgen replacement and quality of life in patients treated for bilateral testicular cancer. |
| Q71916439 | Androgens and bone |
| Q79811504 | Androgens and bone |
| Q37054103 | Bone Mineral Status in Children and Adolescents with Klinefelter Syndrome |
| Q37826806 | Bone density and risk of osteoporosis in Klinefelter syndrome |
| Q53066841 | Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in Klinefelter syndrome. |
| Q33839993 | Bone histology in young adult osteoporosis |
| Q45186434 | Bone histomorphometry in men with spinal osteoporosis |
| Q51591554 | Bone mass and mineral metabolism in Klinefelter's syndrome. |
| Q44025886 | Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis. |
| Q43622940 | Bone turnover markers and sex hormones in men with idiopathic osteoporosis |
| Q41241542 | Corticosteroid-induced bone loss. Prevention and management |
| Q34203708 | Decreased DNA synthesis by cultured osteoblastic cells in eugonadal osteoporotic men with defective bone formation |
| Q41197292 | Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate |
| Q34666342 | Effects of cirrhosis on bone mineral density and bone metabolism |
| Q38749092 | Histomorphometric analysis of bone in metabolic bone disease. |
| Q41700884 | Immunologic aspects of osteoporosis |
| Q37311300 | Impact on bone of an estrogen receptor-alpha gene loss of function mutation |
| Q68201898 | Impaired bone formation in male idiopathic osteoporosis: further reduction in the presence of concomitant hypercalciuria |
| Q50890431 | Long-term follow-up of bone mineral density and bone metabolism in transsexuals treated with cross-sex hormones. |
| Q35174818 | MELD score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease |
| Q33687994 | Male Skeletal Health and Osteoporosis |
| Q41387473 | Male menopause. How to define it, how to treat it. |
| Q33610301 | Male osteoporosis and androgenic therapy: from testosterone to SARMs. |
| Q36255238 | Male osteoporosis: new trends in diagnosis and therapy |
| Q74350831 | Mechanisms of bone loss after cardiac transplantation |
| Q71871706 | Osteoporosis as a Complication of Orchiectomy in 2 Elderly Men with Prostatic Cancer |
| Q67551566 | Osteoporosis in men |
| Q72736936 | Osteoporosis in men |
| Q35675197 | Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies |
| Q40914032 | Osteoporosis in men. Is it more common than we think? |
| Q40829310 | Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management |
| Q34034405 | Osteoporosis. Pathogenesis, diagnosis, and treatment in older adults |
| Q74777731 | Osteoporosis: pathogenesis, diagnosis, and treatment in older adults |
| Q31866905 | Progressive decrease in bone density over 10 years of androgen deprivation therapy in patients with prostate cancer. |
| Q33617599 | Prolactinoma in a middle-aged man with an osteoporotic fracture |
| Q67467248 | Prolonged treatment with finasteride (a 5α‐reductase inhibitor) does not affect bone density and metabolism |
| Q36661802 | Recent experimental and clinical findings in the skeleton associated with loss of estrogen hormone or estrogen receptor activity |
| Q44876862 | Risk of osteoporosis in men with chronic bronchitis |
| Q73509256 | Secondary osteoporosis |
| Q74787546 | Secondary osteoporosis. Diagnostic considerations |
| Q50871961 | Sex hormone status and bone metabolism in men with Crohn's disease. |
| Q41178930 | Spontaneous multiple vertebral fractures revealed primary haemochromatosis |
| Q33745729 | Testosterone replacement therapy in older adult men. |
| Q33723618 | The effects of testosterone on osteoporosis in men. |
| Q58126560 | The microanatomy of trabecular bone in young normal and osteoporotic elderly males |
| Q37040820 | The relationship between periodontal status and alkaline phosphatase levels in gingival crevicular fluid in men with hypergonadotropic hypogonadism |
| Q35124704 | Therapeutic benefit of bisphosphonates in the management of prostate cancer-related bone disease |
| Q64982442 | Therapeutic role of androgens in the treatment of osteoporosis in men. |
| Q40696809 | Trophic factors in aging. Should older people receive hormonal replacement therapy? |
| Q44036956 | UCLA Geriatric Grand Rounds: Osteoporosis |
| Q39554946 | Use of calciferol and its metabolites and analogues in osteoporosis. Current status |
| Q35549207 | Vertebral fractures and bone mineral density in idiopathic, secondary and corticosteroid associated osteoporosis in men. |
| Q77421310 | [Aetiologic features of osteoporosis in male patients aged less than 50 years: study of 28 cases with a comparative series of 30 patients over the age of 50] |
Search more.